Stockreport

CervoMed to Participate in the 4th Annual ROTH Healthcare Opportunities Conference

CervoMed Inc.  (CRVO) 
PDF BOSTON, Oct. 02, 2025 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders [Read more]